U.S. NALOXONE MARKET ANALYSIS

Market Concentration and Competitive Landscape

Close-monitor your Competitor's Move, Request sample copy

Government initiatives to expand access

The U.S government has taken several initiatives to expand access to naloxone, and this drives the naloxone market growth. Naloxone is an opioid antagonist that is used to reverse opioid overdoses, and it can save lives during an overdose emergency. The ongoing opioid crisis in the U.S. compelled government agencies to focus on increasing the availability of naloxone nationwide. For example, through programs like State Opioid Response (SOR) grants, Substance Abuse and Mental Health Services Administration (SAMHSA) has awarded billions in funds to state governments to support opioid treatment and prevention efforts. This funding will be used to exapand naloxone distribution and teach  overdose prevention education. As a result, all 50 U.S. states now have standing orders or other policies that allow pharmacists to dispense naloxone without an individual prescription. Community-based programs partnering with health departments, police and EMS have also received funding to set up naloxone distribution sites across cities and towns. These efforts are steadily increasing access to and utilization of naloxone. According to the data from SAMHSA,  the number of naloxone kits distributed through their funded programs had increased from under 700,000 in 2017 to over 2.6 million in 2020. As per CDC Provisional Data, EMS administrations of naloxone for suspected opioid overdoses doubled from just under 50,000 in 2016 to over 140,000 in 2021.